Yosuke Kameoka

Medicine · Health Sciences

20h-index1.3kcitations81works0.32yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Vasculitis and related conditions(14), Neutrophil, Myeloperoxidase and Oxidative Mechanisms(8), Chromosomal and Genetic Variations(7), Genomics and Chromatin Dynamics(6), Parasites and Host Interactions(6)

Publications81 total

A combination of VAP2 and SDF-1a as a candidate risk factor for coronary artery lesion formation in Kawasaki disease patients
SSRN Electronic Journal·2025Open Access
Dynamics of scFv-targeted VAP2 correlating with IL-16, MIF and IL-1Ra in ANCA-associated vasculitis
Microvascular Research·2024· 1 cited
Dynamics of Scfv-Targeted Vap2 Correlating with Il-16, Mif and Il-1ra in Anca-Associated Vasculitis
SSRN Electronic Journal·2024Open Access
Enhanced efficacy of the novel recombinant clone VasSF in a mouse model of antineutrophil cytoplasmic antibody-associated vasculitis
Clinical & Experimental Immunology·2023· 3 citedOpen Access
Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease
Pediatric Rheumatology·2022· 5 citedOpen Access
Beneficial Effects of Anti-Apolipoprotein A-2 on an Animal Model for Coronary Arteritis in Kawasaki Disease
2022Open Access
Impact of Two Novel Mutations on the Structure and Function of Human Myeloperoxidase
UNC Libraries·2021Open Access
VasSF treatment increased the number of pup deliveries per female in SCG/Kj mice
2021· 1 cited
Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice
Autoimmunity·2019· 7 citedOpen Access
Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis [Corrigendum]
SHILAP Revista de lepidopterología·2019Open Access
<p>Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis [Corrigendum]</p>
Drug Design Development and Therapy·2019Open Access
051. MOESIN EXPRESSION LEVEL OF MPO-ANCA ASSOCIATED-VASCULITIS MODEL MICE
Lara D. Veeken·2019Open Access
175. VASCULITIS AND GLOMERULONEPHRITIS IN A NEWLY ESTABLISHED CONGENIC MICE STRAIN DERIVED FROM ANCA- ASSOCIATED VASCULITIS-PRONE SCG/KJ MICE
Lara D. Veeken·2019· 1 citedOpen Access
352. NEW DRUG FOR VASCULITIS: EFFICACY OF A RECOMBINANT SINGLE-CHAIN FRAGMENT VARIABLE REGION, VASSF
Lara D. Veeken·2019Open Access
Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis
SHILAP Revista de lepidopterología·2019Open Access
<p>Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis</p>
Drug Design Development and Therapy·2019· 5 citedOpen Access
IgGの可変領域(HscFv)の組換え単鎖断片の投与はの水溶性画分により誘発されるマウスCandida albicans血管炎の発生を抑制する 川崎病の動物モデル
2019
Administration of recombinant single chain fragment of variable region (hScFv) of IgG suppresses development of murine vasculitis induced with Candida albicans water-soluble fraction: An animal model of Kawasaki disease.
2019· 2 cited
The Rare Disease Bank of Japan: establishment, current status and future challenges
Human Cell·2018· 9 cited
日本の希少疾患バンク:確立,現状および今後の課題
2018
page 1 of 5Next →

Frequent Co-authors

Kazuo Suzuki(15), Katsuyuki Hashimoto(10), Ichiro Takahashi(9), Makoto Hirata(7), Naoki Osada(7), Keiji Terao(5), Jun Kusuda(5), Hiromu Sugiyama(5), Atsunori Higashino(4), Yasuyuki Morishima(4), Naohito Ohno(4), Amanda S. Persad(4), Fuyu Ito(4), Minako Koura(4), Toshinori Nakayama(4), Yohko T. Arai(3), Reiko Tanuma(3), Tohru Masui(3), Satoshi Yamagoe(3), Noriko N. Miura(3)